Guosheng Securities maintains Tigermed's buy rating: its main business will resume quarter by quarter, optimistic about long-term rapid development | China Business Blog

Aggregated China Business Blogs

2021-01-28

Guosheng Securities maintains Tigermed's buy rating: its main business will resume quarter by quarter, optimistic about long-term rapid development

Aggregated Source: Caishen.Co

Caishen.Co delivers Primary Data for China`s Secondary Investment and Stock Markets. Full details at Caishen.Co.

Original URL: Click here to visit original article
Copyright Caishen.Co